Condition
Metabolic Effects
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+14% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Not Yet Recruiting1
Completed1
Recruiting1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05652478Phase 2Recruiting
Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study
NCT07024238Not ApplicableEnrolling By InvitationPrimary
Impact of SCFA Supplementation on Gut Microbiome Composition of Kidney Transplant Recipients
NCT06951581Not ApplicableCompletedPrimary
Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients.
NCT06929637Not ApplicableNot Yet Recruiting
Amino Acid Infusion in Kidney Transplant Recipients
Showing all 4 trials